Google
SLGC — SOMALOGIC INC (Healthcare >> Health Information Services)
SLGC FAQ
What is SLGC's ROE?
SOMALOGIC INC reports a Return on Equity (ROE) of -26.25%.
What is SLGC's dividend yield?
SOMALOGIC INC offers a dividend yield of 0.00%.
What is SLGC's Deepscope Quality Score?
Deepscope rates SLGC's overall financial quality at 8 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SLGC?
Deepscope's AI Timing Score for SLGC is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SLGC belong to?
SOMALOGIC INC is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange.
|
USD 19.34
Price
-0.03
(-0.15%)
Day Change
|
|
|---|
SLGC, the overall quality is not good ( Quality = 8) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 19.34 |
| PBV / Sector |
0.80 / 4.52
GREAT
|
| Earning Per Share | -6.36 |
| PE / Sector |
N/A / 45.70
|
| PEG or PE/Growth / Sector |
N/A / -0.26
|
| Average 1M Daily Value |
0.09 M
GREAT
|
| Average 1W Daily Value |
0.03 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:42 |
| Symbol | SLGC |
| Name | SOMALOGIC INC |
| Sector | Healthcare >> Health Information Services |
| Market | NASDAQ |
| Listed Shares | 188.68 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 396.23 / 3,839.73 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2945 Wilderness Place, Boulder, CO, United States, 80301
Phone: 303 625 9000
Website: https://www.somalogic.com
Employees: 451
Description: SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.
ME vs SECTOR Healthcare >> Health Information Services
Click a bubble to view stock details · Bubble size represents market capitalization share
